Ling-Hua Meng (Linghua Meng)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Regulatory T Cells

Cell Cycle Arrest

Vascular Endothelial Growth Factor

Top Venues

Signal transduction and targeted therapy

Cell death & disease

Clinical and translational medicine

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Xu Zhang, Yu-Xiang Wang, Xi Zhang, Yanyan Shen, Kang Yang, Qingyang Ma, Yuemei Qiao, Jiajie Shi, Yi Wang, Lan Xu, Biyu Yang, GaoXiang Ge, Landian Hu, Xiangyin Kong, Chunhao Yang, Yi Chen, Jian Ding, Ling-Hua Meng
Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors. Signal transduction and targeted therapy 8 (1) (2023)
Hui Xing, Mengshi Gao, Yuxiang Wang, Xu Zhang, Jiajie Shi, Xiang Wang, Xueling Liu, Qingyang Ma, Xiangyin Kong, Chunhao Yang, Jian Ding, Ling-Hua Meng
Genome-wide gain-of-function screening identifies EZH2 mediating resistance to PI3Kα inhibitors in oesophageal squamous cell carcinoma. Clinical and translational medicine 12 (5) (2022)
Yu-Xiang Wang, Xu Zhang, Qing-Yang Ma, Lan-Dian Hu, Xi Zhang, Yi Wang, Lan Xu, Chun-Hao Yang, Cun Tan, Xiang-Yin Kong, Jian Ding, Ling-Hua Meng
Adaptive resistance to PI3Kα-selective inhibitor CYH33 is mediated by genomic and transcriptomic alterations in ESCC cells. Cell death & disease 12 (1) (2021)
Qin Xie, Shuaishuai Chi, Yanfen Fang, Yiming Sun, Ling-Hua Meng, Jian Ding, Yi Chen
PI3Kα inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma. Signal transduction and targeted therapy 6 (1) (2021)
Xue-Ling Liu, Jia-Li Liu, Yi-Chao Xu, Xi Zhang, Yu-Xiang Wang, Li-Hua Qing, Wei Guo, Jian Ding, Ling-Hua Meng
Membrane metallo-endopeptidase mediates cellular senescence induced by oncogenic PIK3CAH1047R accompanied with pro-tumorigenic secretome. International journal of cancer 145 (3) (2019)